Clinical trial
Assessment of the Performance of a New Suture Material (Optilene® Suture) for Coronary Artery Bypass Graft Surgery. An Observational Post CE-mark Study
NCT02546557 is registered in ClinicalTrials.gov with Aesculap AG as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Assessment of the Performance of a New Suture Material (Optilene® Suture) for Coronary Artery Bypass Graft Surgery. An Observational Post CE-mark Study
- Lead sponsor
- Aesculap AG
- Phase
- Observational
- Overall status
- Completed
- Start date
- November 10, 2015
- Completion date
- October 31, 2018
- Enrollment
- 245 (actual)
- Sites
- 4
Conditions
As the registry lists them; a condition with its own page is linked.
coronary heart disease, multi vessel coronary artery disease